CMS Changes Part D MTM Criteria, Including Addition Of HIV Drugs

Among three key changes CMS finalized to improve the targeting criteria of the Medicare Part D Medication Therapy Management (MTM) program, the agency has decided to add HIV/AIDS to the list of core chronic diseases an enrollee must have to be eligible for the program. Due to the high number of drugs HIV/AIDS patients take alongside their high number of comorbidities, and likelihood of those patients to be a part of populations affected by disparities, advocates for greater HIV/AIDS treatment...